Success Stories: Rapid NIW Approval for Translational Epidemiology Specialist Shaping U.S. Chronic Disease Treatment Strategies

Client’s Testimonial:

“Thank you so much for this excellent news! And thank you so much for all your help throughout this process.”

On June 5^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Research Specialist in the Field of Translational Epidemiology (Approval Notice).

General Field: Translational Epidemiology

Position at the Time of Case Filing: Senior Research Specialist

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: June 5^th, 2025

Processing Time: 20 days (Premium Processing Requested)

Case Summary:

As a leading figure in translational epidemiology, our client has built a distinguished career at the intersection of public health, clinical science, and statistical modeling. Her proposed endeavor, to advance the development of quantitative clinical decision-making tools, aims to enable earlier and more precise interventions for chronic, life-altering diseases. Her work plays a crucial role in improving outcomes for high-risk patient populations while also supporting global healthcare sustainability.

Through the application of advanced epidemiological and statistical methods, her research enables early detection protocols and empowers clinicians with actionable insights. Her analytical contributions foster timely diagnoses, more personalized treatments, and a reduction in preventable deaths.

Beyond clinical utility, our client’s findings support the design of cost-effective therapeutic strategies that minimize unnecessary treatments and reduce the economic burden of long-term disease management. Her work has been especially impactful in nephrology, where her research has helped refine therapeutic pathways and optimize patient outcomes in complex kidney diseases.

Recognizing the national significance of her work, our client’s research has received funding support from the National Kidney Foundation, further underscoring its alignment with public health priorities.

Her academic record reflects both productivity and impact:

➔ 14 peer-reviewed journal articles, with 1 as first author,

➔ 5 conference abstracts, including 3 first-authored,

➔ A total of 332 citations, and

➔ 7 peer reviews completed for professional journals.

“To summarize my thoughts, [client] provided critical insights into unexplored areas of kidney disease research and her contributions facilitated drug development in academic medical centers, the pharmaceutical industry, and in health authorities worldwide. Her accomplishments have offered substantial benefits to nephrology patients, caregivers, and payors far beyond her work to advance the study of IgAN.”

In light of her exceptional qualifications and the substantial national importance of her proposed endeavor, the North America Immigration Law Group (NAILG) prepared and submitted her National Interest Waiver (NIW) petition. The case clearly demonstrated how our client’s ongoing research supports both public health and healthcare innovation in the United States.

With NAILG’s expertise, the petition was approved, formally recognizing her as a vital contributor to the advancement of data-driven, equitable, and cost-conscious care for patients with chronic diseases.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.